γ-Vinyl GABA: comparison of neurochemical and anticonvulsant effects in mice

作者: R. Bernasconi , M. Klein , P. Martin , P. Christen , T. Hafner

DOI: 10.1007/BF01243421

关键词:

摘要: Biochemical and pharmacological effects ofγ-vinyl GABA (Vigabatrin®, GVG), an irreversible enzyme-activated inhibitor of 4-aminobutyrate: 2-oxoglutarate aminotransferase (EC 2.6.1.19; GABA-T), were measured in mice. This anticonvulsant produced a time- dose-dependent elevation the GABA, phenylalanine lysine contents cortical tissue simultaneously decreased glutamate, aspartate alanine levels. In addition, GVG caused biphasic change glutamine concentrations (a decline 1–4 hours after administration, followed 20 later by increase). Moreover, we found new, as yet unidentified amino acid brain eluting with same retention time α-aminoadipic from HPLC cation-exchange column. The level this novel chemical entity was greatly increased injection drug. At all tested intervals between 1 60 injection, ineffective against maximal electroshock. GABA-T dose-dependently protected mice isoniazid-induced seizures, causing increase concentrations. However, apparent correlation applied only until 4 treatment. To better define profile GVG, groups treated, 1, 2, 4, 24 prior to challenge convulsant doses strychnine, pentetrazole (PTZ), picrotoxin, levels, including measured. instances, dependency increases levels differed. Amino animals treated similar those given convulsant. showed no selectivity for seizures impairment GABA-ergic neurotransmission. Although is effective inhibitor, it apparently affects several other pyridoxal-phosphate-dependent cerebral enzymes and/or interacts neurotransmitter systems well.

参考文章(24)
Gale K, Role of the substantia nigra in GABA-mediated anticonvulsant actions. Advances in Neurology. ,vol. 44, pp. 343- 364 ,(1986)
B.S. Meldrum, Epilepsy and γ-Aminobutyric Acid-Mediated Inhibition International Review of Neurobiology. ,vol. 17, pp. 1- 36 ,(1975) , 10.1016/S0074-7742(08)60205-6
P. Loiseau, J. P. Hardenberg, M. Pestre, M. Guyot, P. J. Schechter, G. P. Tell, Double‐Blind, Placebo‐Controlled Study of Vigabatrin (Gamma‐Vinyl GABA) in Drug‐Resistant Epilepsy Epilepsia. ,vol. 27, pp. 115- 120 ,(1986) , 10.1111/J.1528-1157.1986.TB03512.X
D.W. Straughan, Convulsant drugs: amino acid antagonism and central inhibition. Neuropharmacology. ,vol. 13, pp. 495- 508 ,(1974) , 10.1016/0028-3908(74)90139-7
J. R. Benson, P. E. Hare, O-phthalaldehyde: fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrin Proceedings of the National Academy of Sciences of the United States of America. ,vol. 72, pp. 619- 622 ,(1975) , 10.1073/PNAS.72.2.619
M. J. Jung, B. Lippert, B. W. Metcalf, P. Böhlen, P. J. Schechter, γ-Vinyl GABA (4 amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T : effects on brain GABA metabolism in mice Journal of Neurochemistry. ,vol. 29, pp. 797- 802 ,(1977) , 10.1111/J.1471-4159.1977.TB10721.X
D.A. Kendall, D.A. Fox, S.J. Enna, Effect of γ-vinyl GABA on bicuculline-induced seizures Neuropharmacology. ,vol. 20, pp. 351- 355 ,(1981) , 10.1016/0028-3908(81)90008-3